"10.1371_journal.pone.0106901","plos one","2014-09-11T00:00:00Z","Beverly L Falcon; Michelle Swearingen; Wendy H Gough; Linda Lee; Robert Foreman; Mark Uhlik; Jeff C Hanson; Jonathan A Lee; Don B McClure; Sudhakar Chintharlapalli","Department of Cancer Angiogenesis, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Department of Quantitative Biology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Department of In Vivo Pharmacology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Department of Informatics Capabilities, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Department of BioTDR, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: BLF MS WHG LL RF MU JAL DBM SC. Performed the experiments: BLF MS WHG LL RF JCH SC. Analyzed the data: BLF MS WHG LL MU JCH DBM SC. Contributed reagents/materials/analysis tools: BLF MS WHG LL MU JCH DBM SC. Contributed to the writing of the manuscript: BLF WHG MU JAL SC.","The work is funded by Lilly Research Laboratories. All of the authors are employees of Eli Lilly and Company and received salary from them. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","09","Beverly L Falcon","BLF",10,TRUE,9,7,8,NA,TRUE,TRUE,FALSE,0,NA,FALSE
